[1,2,4]Triazolo[4,3- a ]phthalazines: Inhibitors of Diverse Bromodomains (original) (raw)

6-Bromo-1-methyl-4-[2-(4-methylbenzylidene)hydrazinylidene]-3 H -2λ 6 ,1-benzothiazine-2,2-dione

Muhammad Shafiq

Acta Crystallographica Section E Structure Reports Online, 2011

View PDFchevron_right

4-Amino-3-(4-hydroxybenzyl)-1 H -1,2,4-triazole-5(4 H )-thione

Manpreet Kaur

Acta Crystallographica Section E Structure Reports Online, 2013

View PDFchevron_right

Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives

Simla Cobanoglu

Journal of Enzyme Inhibition and Medicinal Chemistry, 2015

View PDFchevron_right

4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo [4,3-a] quinazolin-5-ones: Novel Class of H 1 -antihistaminic Agents

T Durai Ananda Kumar

Chemical Biology & Drug Design, 2007

View PDFchevron_right

1,3,5-Tris(bromo-methyl)benzene

Jose Fernandes

Acta Crystallographica Section C: Crystal Structure Communications, 2011

View PDFchevron_right

4-Methylbenzyl 4-aminobenzoate

Ali Haider

Acta Crystallographica Section E Structure Reports Online, 2010

View PDFchevron_right

Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors

Jamin Boggs

Bioorganic & medicinal …, 2007

View PDFchevron_right

Development of novel benzotriazines for drug discovery

richard soll

Expert Opinion on Drug Discovery, 2009

View PDFchevron_right

Synthesis and biological evaluation of new non-imidazole H3-receptor antagonists of the 2-aminobenzimidazole series

Elisabetta Barocelli

Bioorganic & Medicinal Chemistry, 2006

View PDFchevron_right

3-(4-Methylpiperazin-1-yl)isobenzofuran-1(3H)-one3-Substituted phthalides. XXXVI

Mustafa Odabasoglu

Acta Crystallographica Section E-structure Reports Online, 2008

View PDFchevron_right

2-Bromo-N-(dibenzylcarbamothioyl)benzamide

Bohari M Yamin

Acta Crystallographica Section E Structure Reports Online, 2011

View PDFchevron_right

6-Bromo-3-{2-[2-(diphenylmethylene)hydrazinyl]-1,3-thiazol-5-yl}-2 H -chromen-2-one chloroform monosolvate

Chan Lam

Acta Crystallographica Section E Structure Reports Online, 2011

View PDFchevron_right

Triazinane Derivatives as Possible Antimicrobial Agents

Dr B.B.L Srivastava

IOSR Journal of Applied Chemistry, 2016

View PDFchevron_right

2-Anilinonicotinyl linked 2-aminobenzothiazoles and [1, 2, 4] triazolo [1, 5-< i> b][1, 2, 4] benzothiadiazine conjugates as potential mitochondrial apoptotic inducers

Dilip Mondhe

2011

View PDFchevron_right

3-(3-Methoxybenzoyl)-1,1-diphenylthiourea

Ibrahim Hassan

Acta Crystallographica Section E Structure Reports Online, 2011

View PDFchevron_right

Delivery systems for some biologically active 1,2,4-triazine derivatives: synthesis and release

Nehal Salahuddin

Polymers for Advanced Technologies, 2009

View PDFchevron_right

2-Bromo-6-hydrazinylpyridine

Thomas Mawhinney

IUCrData, 2023

View PDFchevron_right

Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains

Shiraz Mujtaba

Journal of Medicinal Chemistry, 2013

View PDFchevron_right

4-Phenyl-1,2,4-triazaspiro[4.5]dec-1-ene-3-thione

Shaaban Mohamed

Acta Crystallographica Section E Structure Reports Online, 2013

View PDFchevron_right

Synthesis and Biological Screening of 4-Benzyl-2H-phthalazine Derivatives

moh abdou

Pharmaceuticals, 2011

View PDFchevron_right

3-Benzyl-5-benzylidene-2-sulfanylidene-1,3-thiazolidin-4-one

Muhammad Faiz Raza

Acta Crystallographica Section E Structure Reports Online, 2011

View PDFchevron_right

New antiprotozoal agents: Their synthesis and biological evaluations

Ram Upadhayaya

Bioorganic & Medicinal Chemistry Letters, 2013

View PDFchevron_right

Synthesis and in vitro cytotoxicity studies of novel triazolo[4,3-b]pyridazinones

Moslem Mohammadi

Journal of the Iranian Chemical Society, 2006

View PDFchevron_right

Two new phenylpiperazines with atypical antipsychotic potential

Goran Roglic

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

Antitumoral activity of a new series of 5,6-dihydrobenzo( a)carbazoles

Horacio Pappa

Journal of Experimental Therapeutics and Oncology, 2002

View PDFchevron_right